$CBNT
C-Bond Systems, Inc Stock $cbnt

$cbnt Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023086882 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023 Q2
Revenue	$745.3K	$814.0K	$414.1K
YoY Change	22.59%	41.89%	-23.38%
Cost Of Revenue	$379.9K	$346.6K	$209.1K
YoY Change	52.76%	40.7%	-0.3%
Gross Profit	$365.3K	$467.3K	$205.0K
YoY Change	1.71%	42.79%	-38.01%
Gross Profit Margin	49.02%	57.42%	49.51%
Selling, General & Admin	$1.139M	$570.0K	$768.9K
YoY Change	19.01%	-30.33%	5.04%
% of Gross Profit	311.84%	121.97%	375.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$28.86K	$20.00K	$20.55K
YoY Change	37.49%	-11.36%	-9.71%
% of Gross Profit	7.9%	4.28%	10.02%
Operating Expenses	$1.152M	$582.0K	$776.8K
YoY Change	19.25%	-29.72%	4.67%
Operating Profit	-$786.2K	-$114.6K	$3.480M
YoY Change	29.65%	-77.11%	-945.66%
Interest Expense	-$49.10K	$58.69K	$166.2K
YoY Change	-91.27%	-86.68%	-54.13%
% of Operating Profit			4.78%
Other Income/Expense, Net		-$49.44K	$294.4K
YoY Change
Pretax Income	-$1.000M	-$160.0K	$3.774M
YoY Change	-21.93%	-83.09%	-473.93%
Income Tax
% Of Pretax Income
Net Earnings	-$1.012M	-$164.1K	$3.774M
YoY Change	-21.48%	-82.66%	-473.93%
Net Earnings / Revenue	-135.73%	-20.16%	911.54%
Basic Earnings Per Share		$0.00	$0.01
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	532.8M shares	523.2M shares	505.0M shares
Diluted Shares Outstanding		524.7M shares	2.349B shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$736.5K	$1.130M	$1.512M
YoY Change	658.53%	640.64%	518.09%
Cash & Equivalents	$736.5K	$1.133M	$1.512M
Short-Term Investments
Other Short-Term Assets	$28.50K	$30.00K	$66.95K
YoY Change	-59.96%	-67.49%	-38.77%
Inventory	$181.7K	$110.3K	$119.1K
Prepaid Expenses		$2.250K	$16.95K
Receivables	$426.5K	$270.8K	$133.3K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.373M	$1.549M	$1.831M
YoY Change	166.4%	164.84%	174.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$330.1K	$183.9K	$79.05K
YoY Change	242.75%	75.68%	-31.03%
Goodwill	$350.5K	$350.5K	$350.5K
YoY Change	0.0%	0.0%	0.0%
Intangibles	$229.4K	$242.0K	$254.7K
YoY Change	-18.04%	-17.26%	-16.55%
Long-Term Investments		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Assets	$0.00	$949.2K
YoY Change	-100.0%
Total Long-Term Assets	$910.0K	$949.2K	$870.8K
YoY Change	-17.92%	-18.01%	-27.9%
TOTAL ASSETS
Total Short-Term Assets	$1.373M	$1.549M	$1.831M
Total Long-Term Assets	$910.0K	$949.2K	$870.8K
Total Assets	$2.283M	$2.498M	$2.702M
YoY Change	40.58%	43.36%	44.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$710.2K	$724.6K	$729.7K
YoY Change	-8.92%	-11.71%	-12.03%
Accrued Expenses	$1.252M	$406.0K	$390.8K
YoY Change	70.05%	-27.35%	-23.99%
Deferred Revenue	$500.7K	$136.4K
YoY Change	2111.95%
Short-Term Debt	$180.0K	$1.030M	$1.031M
YoY Change	-82.55%	39.19%	155.22%
Long-Term Debt Due	$81.91K	$80.00K	$83.21K
YoY Change	-94.8%	-94.76%	-92.63%
Total Short-Term Liabilities	$2.725M	$2.824M	$2.907M
YoY Change	-43.98%	-33.85%	-16.01%
LONG-TERM LIABILITIES
Long-Term Debt	$960.2K	$60.00K	$5.550K
YoY Change	35.23%	-77.19%	-97.95%
Other Long-Term Liabilities	$97.25K	$110.0K	$128.7K
YoY Change	-62.44%	-62.0%	-59.78%
Total Long-Term Liabilities	$1.057M	$173.1K	$134.3K
YoY Change	9.13%	-68.67%	-77.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.725M	$2.824M	$2.907M
Total Long-Term Liabilities	$1.057M	$173.1K	$134.3K
Total Liabilities	$3.924M	$2.997M	$3.041M
YoY Change	-32.73%	-37.84%	-24.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$60.85M	-$59.84M	-$59.63M
YoY Change	-2.94%	-2.55%	-1.35%
Common Stock	$532.8K	$532.8K	$523.2K
YoY Change	52.12%	63.57%	70.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.641M	-$3.455M	-$454.9K
YoY Change
Total Liabilities & Shareholders Equity	$2.283M	$2.498M	$2.702M
YoY Change	40.58%	43.36%	44.15%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$1.012M	-$164.1K	$3.774M
YoY Change	-21.48%	-82.66%	-473.93%
Depreciation, Depletion And Amortization	$28.86K	$20.00K	$20.55K
YoY Change	37.49%	-11.36%	-9.71%
Cash From Operating Activities	-$372.2K	-$320.0K	-$622.0K
YoY Change	-7.36%	-16.61%	110.43%
INVESTING ACTIVITIES
Capital Expenditures	$4.770K	$110.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$11.63K	$0.00	$4.043M
YoY Change	111.45%
Cash From Investing Activities	$6.860K	-$110.0K	$4.043M
YoY Change	24.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-35.27K	60.00K	-1.992M
YoY Change	-110.35%	-79.44%	-638.34%
NET CHANGE
Cash From Operating Activities	-372.2K	-320.0K	-622.0K
Cash From Investing Activities	6.860K	-110.0K	4.043M
Cash From Financing Activities	-35.27K	60.00K	-1.992M
Net Change In Cash	-400.6K	-370.0K	1.429M
YoY Change	622.12%	302.26%	1819.05%
FREE CASH FLOW
Cash From Operating Activities	-$372.2K	-$320.0K	-$622.0K
Capital Expenditures	$4.770K	$110.0K
Free Cash Flow	-$377.0K	-$430.0K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-53029
	dei	Entity Registrant Name EntityRegistrantName	C-BOND SYSTEMS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1315585
	dei	Entity Address Address Line1 EntityAddressAddressLine1	6035 South Loop East
	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77033
	dei	City Area Code CityAreaCode	832
	dei	Local Phone Number LocalPhoneNumber	649-5658
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	532818051	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1133129	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97091	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	270803	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	269442	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	110339	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	77446	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	34863	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	71171	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	279	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1549134	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		usd
	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	515429	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	183886	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	96306	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	172754	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	375412	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	242040	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	279918	usd
CY2023Q3	us-gaap	Goodwill Goodwill	350491	usd
CY2022Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	6482	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	949171	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1108609	usd
CY2023Q3	us-gaap	Assets Assets	2498305	usd
CY2022Q4	us-gaap	Assets Assets	1624038	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1031250	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1031250	usd
CY2023Q3	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	80695	usd
CY2022Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	1576438	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	724603	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	779765	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	405995	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	736393	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	385423	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	590632	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	136427	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	22637	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	59548	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	117671	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2824327	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4864813	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	251263	usd
CY2023Q3	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	59869	usd
CY2022Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	208804	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	113206	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	258895	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	173075	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	968962	usd
CY2023Q3	us-gaap	Liabilities Liabilities	2997402	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5833775	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	532818051	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	532818051	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	350270172	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	350270172	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	532818	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	350270	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55852477	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55141503	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-59840149	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62693184	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3454854	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7201411	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	144037	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	150742	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3310817	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2498305	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1624038	usd
CY2023Q3	us-gaap	Revenues Revenues	813951	usd
CY2022Q3	us-gaap	Revenues Revenues	573649	usd
	us-gaap	Revenues Revenues	1743226	usd
	us-gaap	Revenues Revenues	1624725	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	346611	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	246346	usd
	us-gaap	Cost Of Revenue CostOfRevenue	801042	usd
	us-gaap	Cost Of Revenue CostOfRevenue	705680	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	467340	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	327303	usd
	us-gaap	Gross Profit GrossProfit	942184	usd
	us-gaap	Gross Profit GrossProfit	919045	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	4445	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	42183	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1025571	usd
CY2023Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	308991	usd
CY2022Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	412642	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1177044	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2253374	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	111005	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	217123	usd
	us-gaap	Professional Fees ProfessionalFees	491958	usd
	us-gaap	Professional Fees ProfessionalFees	663387	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	161975	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	198362	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	483279	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	588366	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	581971	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	828127	usd
	us-gaap	Operating Expenses OperatingExpenses	2152281	usd
	us-gaap	Operating Expenses OperatingExpenses	3505127	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4051709	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-114631	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-500824	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2841612	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2586082	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	9250	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	471831	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-231395	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-58301	usd
CY2022Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-440552	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-420276	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1051437	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-49437	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-445566	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	45506	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1289079	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-164068	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-946390	usd
	us-gaap	Profit Loss ProfitLoss	2887118	usd
	us-gaap	Profit Loss ProfitLoss	-3875161	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	28657	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8529	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6705	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-31615	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	13483	usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	14619	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	40788	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	46246	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-206208	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-952480	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2853035	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3889792	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	524747583	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	319825057	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	478703698	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	299609959	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	524747583	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	319825057	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2355294011	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	299609959	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	300000	usd
CY2023Q1	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	40000	usd
CY2023Q1	cbnt	Stock Issued During Period Value For Accrued Compensation StockIssuedDuringPeriodValueForAccruedCompensation	53000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	101400	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	13687	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	12137	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-723087	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7280906	usd
CY2023Q2	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	39450	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	26000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	82600	usd
CY2023Q2	cbnt	Stock Issued During Period Value For Conversion Of Debt Accrued Interest And Fees StockIssuedDuringPeriodValueForConversionOfDebtAccruedInterestAndFees	200389	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	13618	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4046	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3774273	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3167766	usd
CY2023Q3	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	4500	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	30000	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	13483	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-164068	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3310817	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3979041	usd
CY2022Q1	cbnt	Stock Issued During Period Value For Accounts Payable StockIssuedDuringPeriodValueForAccountsPayable	2174	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14250	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12000	usd
CY2022Q1	cbnt	Stock Issued During Period Value In Connection With Debt StockIssuedDuringPeriodValueInConnectionWithDebt	12963	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	14005	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	42702	usd
CY2022Q1	cbnt	Adjustment To Additional Paid In Capital Beneficialconversionchargeforissuanceof Series Bpreferredsharesforaccruedcompensation AdjustmentToAdditionalPaidInCapitalBeneficialconversionchargeforissuanceofSeriesBpreferredsharesforaccruedcompensation	957556	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1919419	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4870820	usd
CY2022Q2	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	102000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	102000	usd
CY2022Q2	cbnt	Stock Issued During Period Value In Connection With Debt StockIssuedDuringPeriodValueInConnectionWithDebt	32736	usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	13920	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	6618	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	325785	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	469899	usd
CY2022Q2	cbnt	Adjustments To Additional Paid In Capital Beneficial Conversion Feature Buyback Related To Debt Extinguishment AdjustmentsToAdditionalPaidInCapitalBeneficialConversionFeatureBuybackRelatedToDebtExtinguishment	-160993	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1009352	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5016047	usd
CY2022Q3	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	91250	usd
CY2022Q3	cbnt	Stock Issued During Period Value In Connection With Debt StockIssuedDuringPeriodValueInConnectionWithDebt	64932	usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	13886	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4445	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-115684	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-946390	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5931380	usd
	us-gaap	Profit Loss ProfitLoss	2887118	usd
	us-gaap	Profit Loss ProfitLoss	-3875161	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	63953	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	68230	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	96075	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	910907	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	29212	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	2250	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	42183	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1025571	usd
	cbnt	Stockbased Professional Fee StockbasedProfessionalFee	119700	usd
	cbnt	Stockbased Professional Fee StockbasedProfessionalFee	228946	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-10331	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7716	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	471831	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-231395	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4051709	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	660	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	586	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8970	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	86571	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	42388	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1287	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	734	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-23763	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-279	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-82805	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-55162	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8721	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	23285	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	122074	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-9641	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	6247	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	26041	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	26927	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	113790	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	53462	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1228280	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1183111	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	114770	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4042631	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3927861	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	275000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	250000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	250000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	291621	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	641260	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1807414	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	75480	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	50000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	222750	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1663543	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	815780	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1036038	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-367331	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97091	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	519898	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1133129	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	152567	usd
	us-gaap	Interest Paid Net InterestPaidNet	225739	usd
	us-gaap	Interest Paid Net InterestPaidNet	15287	usd
	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices	83950	usd
	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices	193250	usd
	us-gaap	Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1 NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1	78000	usd
	cbnt	Series B Preferred Stock Issued For Accrued Compensation SeriesBPreferredStockIssuedForAccruedCompensation	144000	usd
	cbnt	Series B Preferred Stock Issued For Accrued Compensation SeriesBPreferredStockIssuedForAccruedCompensation	278654	usd
	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	40788	usd
	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	41811	usd
	cbnt	Deemed Dividend Related To Ratchet Provision DeemedDividendRelatedToRatchetProvision	4435	usd
	cbnt	Increase In Debt Discount And Paidin Capital For Shares Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForSharesIssuedWithConvertibleDebt	110631	usd
	cbnt	Increase In Debt Discount And Paidin Capital For Warrants Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForWarrantsIssuedWithConvertibleDebt	325785	usd
	us-gaap	Stock Issued1 StockIssued1	2174	usd
	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	214000	usd
	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	114000	usd
	us-gaap	Notes Issued1 NotesIssued1	198139	usd
	cbnt	Increase In Right Of Use And Lease Liability IncreaseInRightOfUseAndLeaseLiability	184375	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 – <span style="text-decoration:underline">NATURE OF ORGANIZATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nature of Organization</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">C-Bond Systems, Inc., together with its subsidiaries (the “Company”), is a materials development company and sole owner, developer, and manufacturer of the patented C-Bond technology. The Company is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. The Company’s primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. During the nine months ended September 30, 2023 and 2022, the Company operated in two segments: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions sold a windshield strengthening, water repellent solution called C-Bond nanoShield™ through May 8, 2023, the date that the nanoShield product line and related technologies were sold (see Note 16). Patriot Glass Solutions sells multi-purpose glass strengthening primer and window film mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry system.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 30, 2021, the Company entered into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Mobile Tint LLC, a Texas limited liability company doing business as A1 Glass Coating (“Mobile”), (ii) the sole member of Mobile (the “Mobile Shareholder”), and (iii) Michael Wanke as the Representative of the Mobile Shareholder. Pursuant to the Exchange Agreement, the Company agreed to acquire 80% of Mobile’s units, representing 80% of Mobile’s issued and outstanding capital stock (the “Mobile Shares”). On July 22, 2021, the Company closed the Exchange Agreement and acquired 80% of the Mobile Shares. The Mobile Shares were exchanged for 28,021,016 restricted shares of the Company’s common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing. Initially, for two years after closing, the Company had the option to acquire the remaining 20% of Mobile’s issued and outstanding membership interests in exchange for a number of shares of the Company’s common stock equal to 300% of Mobile’s average EBIT value, divided by the price of the Company’s common stock as defined in the Exchange Agreement. On September 20, 2023, the Company and the Mobile Shareholder entered into amendment #2 to the Exchange Agreement (the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option (the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending on 5:00 P.M. EST on the date that is thirty calendar days after the Option Start Date (the “Option Period”), to acquire the remaining 20% of Mobile Units (the “Additional Units”), representing 20% of Mobile’s issued and outstanding membership interests, collectively (the “Additional Closing”) (See Note 10). Mobile provides quality window tint solutions for auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Mobile also carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Mobile’s owner-operator, Mr. Wanke, joined the Company as President of its Patriot Glass Solutions division.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 8, 2023, the Company entered into an Asset Purchase Agreement (“APA”) with Apex Protect GPS, LLC (the “Buyer”), whereby the Company sold its C-Bond nanoShield™ business, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield division (the “Assets”) to the Buyer. Accordingly, the Company assigned, transferred and delivered to the Buyer, free and clear of all liens, all of the Assets. Following the Closing, the Parties entered into an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among the Company (“Seller”); Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing to Assignee. The Seller and Assignee also entered into a Lease and Assignment and Assumption Agreement on June 15, 2023 (the “Assignment Agreement”), wherein the Seller assigned to Assignee, and Assignee took assignment from the Seller, of the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to the Assignment Agreement (See Note 16).</p>
	us-gaap	Profit Loss ProfitLoss	2887118	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4042631	usd
CY2023Q3	us-gaap	Cash Cash	1133129	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates during the nine months ended September 30, 2023 and 2022 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash equity transactions. </p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks and Uncertainties</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. On September 30, 2023, the Company had cash in bank in excess of FDIC insured levels of $814,353. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits. Any material loss that the Company may experience in the future could have an adverse effect on its ability to pay its operational expenses or make other payments and may require the Company to move its cash to other high quality financial institutions.<b> </b>Currently, the Company is reviewing its bank relationships in order to mitigate its risk to ensure that its exposure is limited or reduced to the FDIC protection limits.</p>
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	814353	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	26648	usd
CY2022Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	102000	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Derivative Financial Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had certain financial instruments that were embedded derivatives. The Company evaluated all its financial instruments to determine if those contracts or any potential embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815-10-05-4, <i>Derivatives and Hedging</i> and 815-40, <i>Contracts in Entity’s Own Equity</i>. This accounting treatment requires that the carrying amount of any embedded derivatives be recorded at fair value at issuance and marked-to-market at each balance sheet date. In the event that the fair value is recorded as a liability, as is the case with the Company, the change in the fair value during the period is recorded as either other income or expense. Upon conversion, exercise or repayment, the respective derivative liability is marked to fair value at the conversion, repayment or exercise date and then the related fair value amount is reclassified to other income or expense as part of gain or loss on extinguishment.</p>
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-206208	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-952480	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2853035	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3889792	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	524747583	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	319825057	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	478703698	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	299609959	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-206208	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-952480	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2853035	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3889792	usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	40788	usd
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	138837	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-206208	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-952480	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3032660	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3889792	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	524747583	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	319825057	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	478703698	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	299609959	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	524747583	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	319825057	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2355294011	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	299609959	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q3	cbnt	Commitment Shares Issued CommitmentSharesIssued	2600000	shares
CY2022Q3	us-gaap	Shares Issued SharesIssued	998008	shares
CY2022Q3	us-gaap	Fair Value Liabilities Measured On Recurring Basis Debt Instrument Valuation Techniques Change In Technique Quantification Of Effect FairValueLiabilitiesMeasuredOnRecurringBasisDebtInstrumentValuationTechniquesChangeInTechniqueQuantificationOfEffect	34606	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1919036011	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1401359349	shares
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	286744	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	304964	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	15941	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35522	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	270803	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	269442	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1501	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	110339	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	75945	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	110339	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	77446	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	110339	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	77446	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	254167	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	263930	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	70281	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	167624	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	183886	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	96306	usd
CY2022Q3	cbnt	Principal And Interest Payments PrincipalAndInterestPayments	21060	usd
CY2022Q3	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.011
	cbnt	Accrued Dividend AccruedDividend	23792	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	352516	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	352516	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	110476	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	72598	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	242040	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	279918	usd
CY2023Q3	us-gaap	Goodwill Goodwill	350491	usd
CY2022Q4	us-gaap	Goodwill Goodwill	350491	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	37878	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	37878	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	50503	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50503	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	41034	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	142040	usd
CY2021Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.10	pure
CY2021Q4	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.50	pure
CY2021Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	680000	usd
CY2021Q4	cbnt	Placement Fees PlacementFees	60000	usd
CY2021Q4	us-gaap	Legal Fees LegalFees	10000	usd
	cbnt	Future Financings Percentage FutureFinancingsPercentage	0.30	pure
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	825000	usd
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.00875
CY2022Q4	cbnt	Penalty Amount PenaltyAmount	206250	usd
CY2022Q4	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.25	pure
CY2022Q4	us-gaap	Interest And Debt Expense InterestAndDebtExpense	206250	usd
CY2022Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.18	pure
CY2022Q2	cbnt	New Warrant Purchase Issued Exercisable Price NewWarrantPurchaseIssuedExercisablePrice	0.025
CY2023Q3	cbnt	Aggregate Noncash Debt Discount AggregateNoncashDebtDiscount	680000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	141511	usd
CY2023Q3	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	100	pure
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	957556	usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.011
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.025
CY2022Q2	cbnt	Deemed Dividents DeemedDividents	3702	usd
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.009
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.009
CY2022Q3	cbnt	Deemed Dividents DeemedDividents	733	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	104250	usd
CY2022Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	100000	usd
CY2022Q4	cbnt	Net Fees NetFees	4250	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	64250	usd
CY2022Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	60000	usd
CY2022Q4	cbnt	Net Fees NetFees	4250	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	54250	usd
CY2023Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	50000	usd
CY2023Q1	cbnt	Net Fees NetFees	4250	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	90731	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	119943	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	119943	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	219882	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	83138	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1031250	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1199750	usd
CY2022Q4	cbnt	Debt Instrument Add Put Premium DebtInstrumentAddPutPremium	90731	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	7968	usd
CY2023Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1031250	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1282513	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1031250	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1031250	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	251263	usd
CY2023Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	141511	usd
CY2022Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1918203	usd
CY2023Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	947	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	132961	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	140564	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	1785242	usd
CY2023Q3	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	80695	usd
CY2022Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	1576438	usd
CY2023Q3	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	59869	usd
CY2022Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	208804	usd
CY2018Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	400000	usd
CY2018Q4	cbnt	Debt Instrument Bering Interest Rate DebtInstrumentBeringInterestRate	0.18	pure
	cbnt	Loan Agreement Description LoanAgreementDescription	In the event that the Company’s accounts receivable balance plus inventory balance is less than paid principal balance of the Note as of December 31, 2018, the Company shall have 45 days (through and until February 15, 2019) to cure such violation and an establish accounts receivable plus inventory equal to the unpaid principal balance of the Note. Commencing March 31, 2019 and at all times thereafter through the remainder of the commitment period and for so long thereafter as there is any amount still due and owing under the Note, the Company must maintain an accounts receivable balances plus inventory such that the outstanding principal borrowed by Company under the Loan Agreement and Note is less than or equal to eighty five percent (85%) of accounts receivable plus fifty percent (50%) of inventory, all as measured at the same point in time.
	cbnt	Debt Instrument Bering Interest Rate DebtInstrumentBeringInterestRate	0.18	pure
CY2023Q2	cbnt	Release Agreement ReleaseAgreement	400000	usd
CY2023Q2	cbnt	Lender Cash Amount LenderCashAmount	200000	usd
CY2023Q2	cbnt	Lender Shares Issued LenderSharesIssued	22000000	shares
CY2023Q2	cbnt	Cash Payments CashPayments	200000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	68000	usd
CY2023Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	132000	usd
CY2023Q2	cbnt	Interest Due InterestDue	317293	usd
CY2022Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	0	usd
CY2022Q2	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	148420	usd
CY2022Q2	cbnt	Commitment Shares Issued CommitmentSharesIssued	1750000	shares
CY2022Q2	cbnt	Principal And Interest Payments PrincipalAndInterestPayments	21060	usd
CY2022Q2	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2023Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	21371481	shares
CY2023Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	21371481	shares
CY2023Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	62000	usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	62000	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	195000	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	In the event that following the Issue Date the closing trading price of the Company’s common stock is then being traded is below $0.011 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.004 per share. The July 2022 Note contains conversion limitations providing that a holder thereof may not convert the Note to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	6441	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022Q3	cbnt	Commitment Shares Issued CommitmentSharesIssued	3300000	shares
CY2022Q3	us-gaap	Shares Issued SharesIssued	773626	shares
	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	The September Commitment Shares and the placement agent shares were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life of the Note. Additionally, the September 2022 Note is convertible into common shares upon an event of default at an initial effective conversion price which was lower than the fair value of common shares based on the quoted closing price of the Company’s common stock on the measurement date. Principal and interest payments shall be made in 9 installments of $23,400 each beginning on the 120th-day anniversary following the issue date and continuing thereafter each 30 days for eight months. The September 2022 Note matures 12 months after issuance and bears interest at a rate of 8% per annum. GS Capital shall have the right at any time following an Event of Default to convert all or any part of the outstanding and unpaid principal, interest, penalties, and all other amounts under the September 2022 Note at a conversion price of $0.009, subject to adjustment as defined in the Note. The Company did not calculate a beneficial conversion feature since the GS Capital July 2022 Note is contingently convertible upon a default on the September 2022 Note. As of December 31, 2022, the Company is not in default on this note. In the event that following the Issue Date the closing trading price of the Company’s common stock is then being traded below $0.009 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.0032 per share. The September 2022 Note contains conversion limitations providing that a holder thereof may not convert the Note to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital September 2022 note by 60 days. Specifically, the maturity date of the GS Capital September 2022 note was extended to November 6, 2023 and the next payment due date was extended to March 6, 2023. In May 2023, the GS Capital September Note and all accrued interest due was paid in full (See Note 16). On September 30, 2023, the principal balance due on the GS Capital September 2022 Note and accrued interest payable amounted to $0. On December 31, 2022, the principal balance due on the GS Capital September 2022 Note amounted to $195,000 and accrued interest payable amounted to $5,001.
CY2022	cbnt	Loss On Debt Extinguishment lossOnDebtExtinguishment	112500	usd
CY2021Q2	cbnt	Secured Promissory Note Amount SecuredPromissoryNoteAmount	500000	usd
CY2021Q2	cbnt	Annual Accrued Interest Percentage AnnualAccruedInterestPercentage	0.08	pure
CY2022	cbnt	Promissory Note Amounted PromissoryNoteAmounted	65863	usd
CY2021Q3	cbnt	Capital Lease Amount CapitalLeaseAmount	95013	usd
CY2023Q3	cbnt	Notes Payable Vehicles And Equipment Loans NotesPayableVehiclesAndEquipmentLoans	12452	usd
CY2022Q4	cbnt	Notes Payable Vehicles And Equipment Loans NotesPayableVehiclesAndEquipmentLoans	39513	usd
CY2022Q4	cbnt	Received Net Proceed ReceivedNetProceed	200000	usd
CY2022Q4	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	200000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	175000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	175000	usd
CY2023Q2	cbnt	Debt Instrument Interest Rate Effectivepercentage DebtInstrumentInterestRateEffectivepercentage	0.08	pure
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	93448	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	58095	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	81642	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	38228	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	6506	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	7191	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	7944	usd
	cbnt	Accrued Dividend AccruedDividend	26920	usd
CY2023Q3	cbnt	Preferred Stock Stated Value PreferredStockStatedValue	1515000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	300000
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	275000	shares
CY2023Q1	cbnt	Stock Issued During Period Value For Accrued Compensation StockIssuedDuringPeriodValueForAccruedCompensation	53000	usd
CY2023Q1	cbnt	Stock Issued During Period Shares For Accrued Compensation StockIssuedDuringPeriodSharesForAccruedCompensation	9636364	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4000000	shares
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	48000	usd
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.012
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	15000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	33000	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3000000	shares
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	54000	usd
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.018
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	2500000	shares
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	31250	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0125
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	15625	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	5454545	shares
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60000	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.011
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	25000	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	35000	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6666667	shares
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	40000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.006
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	40000	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5000000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22500	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0045
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	22500	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1500000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16950	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0011
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	16950	usd
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1000000	shares
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4500	usd
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0045
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2250	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2250	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	500000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14250	usd
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0285
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	1000000	shares
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11000	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.011
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	2000000	shares
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	24000	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.012
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2500000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26000	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0104
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42183	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	53764	usd
	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	16970120	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.119
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	2000000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.021
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	14970120	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.132
CY2022Q3	us-gaap	Common Stock Conversion Basis CommonStockConversionBasis	In connection with the July 2022 GS Capital Note, on July 28, 2022, the Company issued 2,600,000 shares of its common stock as a commitment fee and the Company issued 998,008 shares of its common stock to the placement agent as a fee for the capital raises. The aggregate of 3,598,008 shares of common stock issued were recorded as a debt discount of $34,606 based on the relative fair value method to be amortized over the life of the July 2022 Note (See Note 8).
CY2022Q3	us-gaap	Common Stock Conversion Basis CommonStockConversionBasis	In connection with the September 2022 GS Capital Note, on September 6, 2022, the Company issued 3,300,000 shares of its common stock as a commitment fee and the Company issued 773,626 shares of its common stock to the placement agent as fee for the capital raises. The aggregate of 4,073,626 shares of common stock issued were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life of the September 2022 Note (See Note 8).
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
	cbnt	Voting Percentage VotingPercentage	0.10	pure
	cbnt	Fair Market Percentage FairMarketPercentage	1.10	pure
	cbnt	Incentive Stock Options IncentiveStockOptions	50000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	11445698	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	29451070	shares
	cbnt	Reported Revenue ReportedRevenue	102569	usd
	cbnt	Bad Debt Expenses BadDebtExpenses	102569	usd
CY2021Q3	us-gaap	Cash Cash	16000	usd
CY2023Q3	cbnt	Settle Agreement SettleAgreement	9000	usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	9250	usd
CY2023Q3	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	0	usd
CY2022Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	18250	usd
CY2021Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	330000	usd
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	240000	usd
CY2021Q3	cbnt	Base Salaries Percentage BaseSalariesPercentage	0.50	pure
	cbnt	Base Salary Bonus Percentage BaseSalaryBonusPercentage	0.50	pure
CY2022Q4	us-gaap	Other Commitments Description OtherCommitmentsDescription	This bonus will be paid 10% in cash ($16,000) which was paid in December 2022 and 90% in equity amounting to $144,000 which as of December 31, 2022 had been accrued and as of December 31, 2022, was included in accrued compensation on the accompanying consolidated balance sheet.
CY2023Q1	us-gaap	Preferred Stock Dividends Shares PreferredStockDividendsShares	144	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.85
	cbnt	Issued Percentage IssuedPercentage	0.20	pure
	cbnt	Outstanding Percentage OutstandingPercentage	0.20	pure
	cbnt	Common Stock Percentage CommonStockPercentage	3	pure
	cbnt	Option Period Percentage OptionPeriodPercentage	0.20	pure
	cbnt	Option To Purchase Twenty Percentage Of Mobile Tint Description OptionToPurchaseTwentyPercentageOfMobileTintDescription	the sum of (i) Mobile’s net income, before income tax expense and interest expense have been deducted, for the period beginning on July 1, 2023 and ending on June 30, 2025 plus (ii) $240,000. “EBIT Value” shall mean the Total EBIT Value divided by two (2). “Share Value” shall mean (i) 300% of the EBIT Value (the “Triple EBIT Value”), minus (ii) the Net Income. “Net Income” shall mean Mobile’s net income, after income tax expense and interest expense have been deducted, for the period beginning on July 1, 2023 and ending on June 30, 2025. Any salary paid by Mobile, including but not limited to any salary paid to the Mobile Shareholder, shall not be included in Net Income.
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	814353	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q3	us-gaap	Revenues Revenues	813951	usd
CY2022Q3	us-gaap	Revenues Revenues	573649	usd
	us-gaap	Revenues Revenues	1743226	usd
	us-gaap	Revenues Revenues	1624725	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22558	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22564	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	63953	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	68230	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	58687	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	445566	usd
	us-gaap	Interest Expense InterestExpense	426325	usd
	us-gaap	Interest Expense InterestExpense	1057684	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-164068	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-946390	usd
	us-gaap	Profit Loss ProfitLoss	2887118	usd
	us-gaap	Profit Loss ProfitLoss	-3875161	usd
CY2023Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	183886	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	96306	usd
	us-gaap	Revenues Revenues	1743226	usd
	us-gaap	Revenues Revenues	1624725	usd
CY2020	us-gaap	Payments For Rent PaymentsForRent	4444	usd
	us-gaap	Payments For Rent PaymentsForRent	4577	usd
CY2022Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P1Y
CY2022Q2	us-gaap	Payments For Rent PaymentsForRent	5283	usd
	us-gaap	Payments For Rent PaymentsForRent	5600	usd
CY2021Q3	cbnt	Lease Agreemen Description LeaseAgreemenDescription	the Company entered into a 48-month lease agreement for the lease of office equipment under a non-cancelable operating lease through September 2025.
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	365	usd
CY2022Q1	cbnt	Lease Agreemen Description LeaseAgreemenDescription	the Company entered into a 36-month lease agreement for the lease of a vehicle under a non-cancelable operating lease through January 2025.
CY2022Q1	us-gaap	Payments For Rent PaymentsForRent	788	usd
	cbnt	Lease And Rental Expenses LeaseAndRentalExpenses	84701	usd
	cbnt	Lease And Rental Expenses LeaseAndRentalExpenses	127700	usd
CY2023Q3	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	279162	usd
CY2022Q4	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	480293	usd
CY2023Q3	cbnt	Operating Lease Right Of Use Asset Amortization Accumulated Amortization OperatingLeaseRightOfUseAssetAmortizationAccumulatedAmortization	106408	usd
CY2022Q4	cbnt	Operating Lease Right Of Use Asset Amortization Accumulated Amortization OperatingLeaseRightOfUseAssetAmortizationAccumulatedAmortization	104881	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	172754	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	375412	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023Q3	cbnt	Lease Liabilities Related To Office Leases Right Of Use Assets LeaseLiabilitiesRelatedToOfficeLeasesRightOfUseAssets	172754	usd
CY2022Q4	cbnt	Lease Liabilities Related To Office Leases Right Of Use Assets LeaseLiabilitiesRelatedToOfficeLeasesRightOfUseAssets	376566	usd
CY2023Q3	cbnt	Current Portion Of Lease Liabilities CurrentPortionOfLeaseLiabilities	-59548	usd
CY2022Q4	cbnt	Current Portion Of Lease Liabilities CurrentPortionOfLeaseLiabilities	-117671	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	113206	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	258895	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	76654	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	70351	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	56000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	203005	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	30251	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	172754	usd
CY2022Q2	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	250000	usd
CY2022Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.06	pure
CY2022Q2	us-gaap	Debt Conversion Original Debt Due Date Of Debt Day Month And Year DebtConversionOriginalDebtDueDateOfDebtDayMonthAndYear	2024-05-02
CY2022Q2	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	200000	usd
CY2023Q3	us-gaap	Other Notes Payable OtherNotesPayable	50000	usd
CY2021Q2	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	15690	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	4000000	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	1989755	usd
CY2023Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	317293	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4051709	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1 NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1		usd
	cbnt	Deemed Dividend Related To Ratchet Provision DeemedDividendRelatedToRatchetProvision		usd
	cbnt	Increase In Debt Discount And Paidin Capital For Shares Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForSharesIssuedWithConvertibleDebt		usd
	cbnt	Increase In Debt Discount And Paidin Capital For Warrants Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForWarrantsIssuedWithConvertibleDebt		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Notes Issued1 NotesIssued1		usd
	cbnt	Increase In Right Of Use And Lease Liability IncreaseInRightOfUseAndLeaseLiability		usd
CY2023Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock		usd
CY2022Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock		usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock		usd
CY2022Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials		usd
CY2023Q3	us-gaap	Inventory Adjustments InventoryAdjustments		usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments		usd
	cbnt	Goodwill Useful Life GoodwillUsefulLife
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023Q3	cbnt	Debt Instrument Add Put Premium DebtInstrumentAddPutPremium		usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2023Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001421636

Files In Submission

Name	View Source	Status
cbnt-20230930_def.xml	Edgar Link	unprocessable
cbnt-20230930_pre.xml	Edgar Link	unprocessable
0001213900-23-086882-index-headers.html	Edgar Link	pending
0001213900-23-086882-index.html	Edgar Link	pending
0001213900-23-086882.txt	Edgar Link	pending
0001213900-23-086882-xbrl.zip	Edgar Link	pending
cbnt-20230930.xsd	Edgar Link	pending
f10q0923ex31-1_cbondsystem.htm	Edgar Link	pending
f10q0923ex31-2_cbondsystem.htm	Edgar Link	pending
f10q0923ex32-1_cbondsystem.htm	Edgar Link	pending
f10q0923_cbondsystem.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
cbnt-20230930_cal.xml	Edgar Link	unprocessable
cbnt-20230930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0923_cbondsystem_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBNT
C-Bond Systems, Inc Stock $cbnt

2023 Q4 Form 10-Q Financial Statement

#000121390023086882 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT C-Bond Systems, Inc Stock $cbnt

2023 Q4 Form 10-Q Financial Statement

#000121390023086882 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT
C-Bond Systems, Inc Stock $cbnt